Published in Sci Rep on August 26, 2016
Interleukin-6 Antagonists in Critically-ill Covid-19 Patients (HEMOCOV) | NCT05218369
Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk. Cardiovasc Diabetol (2017) 0.75
Origin and physiological roles of inflammation. Nature (2008) 11.68
The interleukin-8 pathway in cancer. Clin Cancer Res (2008) 7.12
The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta (2011) 5.72
Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev (2006) 5.27
Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer. J Leukoc Biol (2006) 3.45
Blocking IL-1 in systemic inflammation. J Exp Med (2005) 3.37
A clinical perspective of IL-1β as the gatekeeper of inflammation. Eur J Immunol (2011) 3.14
Bidirectional relation between inflammation and coagulation. Circulation (2004) 3.00
IL-1 pathways in inflammation and human diseases. Nat Rev Rheumatol (2010) 2.99
Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity. Mediators Inflamm (2005) 2.63
The hemostatic system as a modulator of atherosclerosis. N Engl J Med (2011) 2.54
IL-6/IL-6 receptor system and its role in physiological and pathological conditions. Clin Sci (Lond) (2012) 2.41
Interleukin 1 and interleukin 18 as mediators of inflammation and the aging process. Am J Clin Nutr (2006) 2.22
IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6. Int J Biol Sci (2012) 2.15
Inflammation and coagulation. Crit Care Med (2010) 2.11
Mechanisms and significance of eryptosis, the suicidal death of erythrocytes. Blood Purif (2012) 2.00
Blood coagulation. Lancet (2000) 1.84
Interleukin-6 and its receptor: from bench to bedside. Med Microbiol Immunol (2006) 1.65
Two-way interactions between inflammation and coagulation. Trends Cardiovasc Med (2005) 1.63
Is IL-1 a good therapeutic target in the treatment of arthritis? Best Pract Res Clin Rheumatol (2006) 1.46
The roles of interleukin-6 in the pathogenesis of rheumatoid arthritis. Arthritis (2011) 1.33
Killing me softly - suicidal erythrocyte death. Int J Biochem Cell Biol (2012) 1.31
Interleukin-6 and its receptors: a highly regulated and dynamic system. Cytokine (2014) 1.26
The effect of inflammation on coagulation and vice versa. Curr Opin Infect Dis (2011) 1.23
Inflammation and coagulation. An overview. Thromb Res (2011) 1.21
Detection of serum TNF-alpha,IFN-beta,IL-6 and IL-8 in patients with hepatitis B. World J Gastroenterol (1999) 1.15
Oxidative stress and suicidal erythrocyte death. Antioxid Redox Signal (2014) 1.08
Tumor necrosis factor receptors in patients with chronic hepatitis B virus infection. Gastroenterology (1995) 1.05
Use of tumor necrosis factor-alpha inhibitors in patients with chronic hepatitis B infection. Semin Arthritis Rheum (2008) 1.04
Toll/interleukin-1 receptor (TIR) domain-mediated cellular signaling pathways. Apoptosis (2015) 1.04
Interleukin 1 receptor 1 and interleukin 1β regulate megakaryocyte maturation, platelet activation, and transcript profile during inflammation in mice and humans. Arterioscler Thromb Vasc Biol (2014) 1.02
CXCR2 in acute lung injury. Mediators Inflamm (2012) 1.02
Changes in red blood cell membrane structure in type 2 diabetes: a scanning electron and atomic force microscopy study. Cardiovasc Diabetol (2013) 1.01
Molecular circuits in thrombosis and inflammation. Thromb Haemost (2013) 1.00
Ceramide in suicidal death of erythrocytes. Cell Physiol Biochem (2010) 0.96
Hypercoagulability, platelet function, inflammation and coronary artery disease acuity: results of the Thrombotic RIsk Progression (TRIP) study. Platelets (2010) 0.95
Enhanced suicidal erythrocyte death in mice carrying a loss-of-function mutation of the adenomatous polyposis coli gene. J Cell Mol Med (2012) 0.95
The relationship between inflammation and the coagulation system. Swiss Med Wkly (2006) 0.95
Physiology and pathophysiology of eryptosis. Transfus Med Hemother (2012) 0.94
Levels of serum IL-1beta, IL-2, IL-8 and tumor necrosis factor-alpha in patients with unstable angina pectoris. Mediators Inflamm (2003) 0.92
The impact of factor XIII on coagulation kinetics and clot strength determined by thrombelastography. Anesth Analg (2004) 0.91
Lipopolysaccharide stimulates platelets through an IL-1β autocrine loop. J Immunol (2013) 0.91
Nitric oxide and pro-inflammatory cytokines in acute hepatitis B. Eur J Intern Med (2004) 0.90
Inflammation, immunity, and vaccines for Helicobacter infection. Helicobacter (2005) 0.89
The effect of dilution on plasma coagulation kinetics determined by thrombelastography is dependent on antithrombin activity and mode of activation. Anesth Analg (2004) 0.89
Inflammation and hypercoagulable state in adult psoriatic men. Acta Derm Venereol (2008) 0.87
Beyond cell based models of coagulation: analyses of coagulation with clot "lifespan" resistance-time relationships. Thromb Res (2007) 0.86
Interleukin 8 and acute lung injury. Arch Pathol Lab Med (2013) 0.86
Eryptosis as a marker of Parkinson's disease. Aging (Albany NY) (2014) 0.86
Disseminated intravascular coagulation: a review for the internist. Intern Emerg Med (2012) 0.85
Sphingosine but not sphingosine-1-phosphate stimulates suicidal erythrocyte death. Cell Physiol Biochem (2011) 0.85
Serum levels of proinflammatory cytokines interleukin-1beta, interleukin-6, and tumor necrosis factor alpha in mixed cryoglobulinemia. Arthritis Rheum (2009) 0.85
Thrombotic storm revisited: preliminary diagnostic criteria suggested by the thrombotic storm study group. Am J Med (2011) 0.85
Dicoumarol activates Ca2+-permeable cation channels triggering erythrocyte cell membrane scrambling. Cell Physiol Biochem (2011) 0.84
Oxysterol mixture in hypercholesterolemia-relevant proportion causes oxidative stress-dependent eryptosis. Cell Physiol Biochem (2014) 0.83
Iron-enhanced coagulation is attenuated by chelation: thrombelastographic and ultrastructural analysis. Blood Coagul Fibrinolysis (2014) 0.83
Thrombelastographic method to quantify the contribution of factor XIII to coagulation kinetics. Blood Coagul Fibrinolysis (2007) 0.82
Platelets in rheumatic diseases: friend or foe? Curr Pharm Des (2014) 0.81
Carbon monoxide and iron modulate plasmatic coagulation in Alzheimer's disease. Curr Neurovasc Res (2015) 0.81
Enhanced suicidal erythrocyte death contributing to anemia in the elderly. Cell Physiol Biochem (2015) 0.80
Predictive value of markers of inflammation in the postthrombotic syndrome: a systematic review: inflammatory biomarkers and PTS. Thromb Res (2015) 0.80
Viscoelastic and ultrastructural characteristics of whole blood and plasma in Alzheimer-type dementia, and the possible role of bacterial lipopolysaccharides (LPS). Oncotarget (2015) 0.80
Coagulation in patients with severe sepsis. Semin Thromb Hemost (2015) 0.79
DMT1-mutant erythrocytes have shortened life span, accelerated glycolysis and increased oxidative stress. Cell Physiol Biochem (2014) 0.79
Accelerated apoptotic death and in vivo turnover of erythrocytes in mice lacking functional mitogen- and stress-activated kinase MSK1/2. Sci Rep (2015) 0.78
Novel path to IL-6 trans-signaling through thrombin-induced soluble IL-6 receptor release by platelets. J Biol Regul Homeost Agents (2013) 0.78
High ferritin levels have major effects on the morphology of erythrocytes in Alzheimer's disease. Front Aging Neurosci (2013) 0.78
An ultrastructural analysis of platelets, erythrocytes, white blood cells, and fibrin network in systemic lupus erythematosus. Rheumatol Int (2013) 0.78
Inflammatory cytokines as biomarkers in heart failure. Clin Chim Acta (2014) 0.78
Vitamin D-Rich Diet in Mice Modulates Erythrocyte Survival. Kidney Blood Press Res (2015) 0.78
The soluble interleukin-6 receptor and related proteins. Best Pract Res Clin Endocrinol Metab (2015) 0.78
Eryptosis Indices as a Novel Predictive Parameter for Biocompatibility of Fe3O4 Magnetic Nanoparticles on Erythrocytes. Sci Rep (2015) 0.78
Poorly controlled type 2 diabetes is accompanied by significant morphological and ultrastructural changes in both erythrocytes and in thrombin-generated fibrin: implications for diagnostics. Cardiovasc Diabetol (2015) 0.77
Impact of Cyclin-Dependent Kinase CDK4 Inhibition on Eryptosis. Cell Physiol Biochem (2015) 0.77
Platelet activation induced by human antibodies to interleukin-8. Blood (2002) 0.77
Phosphatidylserine externalization and procoagulant activation of erythrocytes induced by Pseudomonas aeruginosa virulence factor pyocyanin. J Cell Mol Med (2016) 0.77
Viscoelasticity and Ultrastructure in Coagulation and Inflammation: Two Diverse Techniques, One Conclusion. Inflammation (2015) 0.77
Qualitative thrombelastographic detection of tissue factor in human plasma. Anesth Analg (2007) 0.76
Lapatinib Induced Suicidal Death of Human Erythrocytes. Cell Physiol Biochem (2015) 0.76
Fucoxanthin Induced Suicidal Death of Human Erythrocytes. Cell Physiol Biochem (2015) 0.76
Evidence of hypercoagulability and inflammation in young patients long after acute cerebral ischaemia. Thromb Res (2006) 0.76
Erythrocytes and their role as health indicator: Using structure in a patient-orientated precision medicine approach. Blood Rev (2016) 0.76
Inflammasome in platelets: allying coagulation and inflammation in infectious and sterile diseases? Mediators Inflamm (2015) 0.76
Therapeutic potential of manipulating suicidal erythrocyte death. Expert Opin Ther Targets (2015) 0.75
Viscoelasticity as a measurement of clot structure in poorly controlled type 2 diabetes patients: towards a precision and personalized medicine approach. Oncotarget (2016) 0.75